España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Basilea Pharmaceutica
BPMUF
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$52.83
At close: Oct 11, 11:35 AM EDT
Get Report
Comment
Basilea Pharmaceutica (BPMUF) Forecast
News
Earnings
Basilea Pharmaceutica (BPMUF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Basilea Pharmaceutica (OTC:BPMUF) Stock
Basilea Pharmaceutica Stock (OTC: BPMUF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, July 15, 2020
Basilea Reports Pfizer has Launched Antifungal Cresemba in Taiwan, Triggering Second Milestone Payment Related to Asia-Pacific
Charles Gross
Monday, June 22, 2020
Basilea Receives CHF 5M Milestone Payment from Pfizer Related to Marketing Authorization of Antifungal Cresemba in Russia
Charles Gross
Wednesday, January 10, 2018
Basilea Announces Completion of License Agreement Extension With Pfizer for Antifungal Cresemba for China and Asia Pacific
Benzinga
Friday, December 01, 2017
Pfizer, Basilea to Develop and Commercialize CRESEMBA in China and Asia Pacific Region
Benzinga
Tuesday, September 12, 2017
Basilea Announces Distribution Agreement with Cardiome to Commercialize Zevtera/Mabelio in Europe, Israel
Benzinga
Thursday, July 20, 2017
Pfizer Completes License Agreement for Exclusive Commercialization Rights in Europe for CRESEMBA ti Treat Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients
Benzinga
Monday, October 12, 2015
Basilea Announces Health Canada Approves ZEVTERA to Treat Bacterial Lung Infections
Benzinga
Monday, December 22, 2014
Swiss Regulatory Authority Approves Basilea's Antibiotic Zevtera for Teatment of Pneumonia
Benzinga
